Clinical Trial Update: Mistletoe Therapy in Primary and Recurrent Inoperable Pancreatic Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating mistletoe therapy in primary and recurrent inoperable pancreatic cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• mistletoe therapy

Snippet

Sponsor: Karolinska University Hospital | Conditions: Pancreatic Cancer | Phase 3 | Status: COMPLETED